You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., June 26, 2014 /PRNewswire/ -- Astellas has named Tatjana Dragovic, J.D., vice president and regional compliance officer for its Americas region. In this role, she will oversee compliance strategies and programs for Astellas in the US, Canada and Latin America. Dragovic assumes this role from Pat McCauley, J.D., who has been named area vice president for Urology and Primary Care Physician Sales at Astellas.
Dragovic will report to Linda Friedman, J.D., senior vice president and general counsel for Astellas in the Americas and will have dotted line reporting to Masao Yoshida, President and CEO of Astellas US. She will become a member of Friedman's leadership team and the Global Compliance Committee for Astellas.
"During her career at Astellas, Tatjana has made significant contributions in the legal area and she is extremely well regarded by her colleagues and clients," said Friedman. "With her strong leadership and breadth of experience, I am confident that Tatjana will continue to further enhance our growing compliance organization. I would also like to thank Pat for his leadership and contributions."
Dragovic joined Astellas in 2007 as senior corporate attorney and was subsequently promoted to assistant general counsel and then associate general counsel, litigation. Dragovic began her career at Sidley Austin LLP in 2000. In this capacity, she represented a variety of pharmaceutical and medical device clients. Dragovic received her undergraduate degree from the University of Illinois at Urbana-Champaign, Ill. and graduated at the top of her class at Loyola University School of Law.
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS.
Photo - http://photos.prnewswire.com/prnh/20140626/122202
Logo - http://photos.prnewswire.com/prnh/20140416/84970
SOURCE Astellas
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.